keyword
MENU ▼
Read by QxMD icon Read
search

Leadless pacing

keyword
https://www.readbyqxmd.com/read/28439940/impact-of-operator-experience-and-training-strategy-on-procedural-outcomes-with-leadless-pacing-insights-from-the-micra-transcatheter-pacing-study
#1
Mikhael El Chami, Robert C Kowal, Kyoko Soejima, Philippe Ritter, Gabor Z Duray, Petr Neuzil, Lluis Mont, Alexander Kypta, Venkata Sagi, J Harrison Hudnall, Kurt Stromberg, Dwight Reynolds
BACKGROUND: Leadless pacemaker systems have been designed to avoid the need for a pocket and transvenous lead. However, delivery of this therapy requires a new catheter-based procedure. This study evaluates the role of operator experience and different training strategies on procedural outcomes. METHODS: A total of 726 patients underwent implant attempt with the Micra transcatheter pacing system (TPS) by 94 operators trained in a teaching laboratory using a simulator, cadaver, and large animal models (lab training) or locally at the hospital with simulator/demo model and proctorship (hospital training)...
April 24, 2017: Pacing and Clinical Electrophysiology: PACE
https://www.readbyqxmd.com/read/28396380/permanent-leadless-cardiac-pacemaker-therapy-a-comprehensive-review
#2
REVIEW
Fleur V Y Tjong, Vivek Y Reddy
A new technology, leadless pacemaker therapy, was recently introduced clinically to address lead- and pocket-related complications in conventional transvenous pacemaker therapy. These leadless devices are self-contained right ventricular single-chamber pacemakers implanted by using a femoral percutaneous approach. In this review of available clinical data on leadless pacemakers, early results with leadless devices are compared with historical results with conventional single-chamber pacing. Both presently manufactured leadless pacemakers show similar complications, which are mostly related to the implant procedure: cardiac perforation, device dislocation, and femoral vascular access site complications...
April 11, 2017: Circulation
https://www.readbyqxmd.com/read/28377192/sudden-cardiac-death-new-approaches-for-implantable-cardioverter-defibrillators-icds
#3
Riccardo Cappato, Hussam Ali
The implantable cardioverter-defibrillator (ICD) has shown its superiority to anti-arrhythmic drugs in the prevention of sudden cardiac death. However, the conventional transvenous ICDs are still associated with substantial risks and comorbidities mainly related to the transvenous leads. The recent advent of an entirely sub-cutaneous ICD (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. Clinical data are growing regarding the safety and efficacy of S-ICD in prevention of sudden cardiac death in selected patients without pacing indications...
March 18, 2017: International Journal of Cardiology
https://www.readbyqxmd.com/read/28365650/advancements-in-pacemaker-technology-the-leadless-device
#4
Mary Leier
Leadless pacemakers will most likely be the future of cardiac pacing. Leadless pacing employs a single-chamber system to pace only the right ventricle and is fully self-contained, which eliminates the need for leads. These systems, implanted by using a transcatheter sheath, are indicated for patients who need right ventricular pacing only. These devices enable patients to avoid lead-related complications, from lead fracture to extraction challenges, as well as pocket-related complications such as infection and disfigurement...
April 2017: Critical Care Nurse
https://www.readbyqxmd.com/read/28192209/a-new-alara-keeping-leadless-pacing-thresholds-as-low-as-reasonably-achievable
#5
EDITORIAL
Joseph E Marine
No abstract text is available yet for this article.
May 2017: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://www.readbyqxmd.com/read/28192207/long-term-performance-of-a-transcatheter-pacing-system-12-month-results-from-the-micra-transcatheter-pacing-study
#6
Gabor Z Duray, Philippe Ritter, Mikhael El-Chami, Calambur Narasimhan, Razali Omar, Jose M Tolosana, Shu Zhang, Kyoko Soejima, Clemens Steinwender, Leonardo Rapallini, Aida Cicic, Dedra H Fagan, Shufeng Liu, Dwight Reynolds
BACKGROUND: Early performance of the Micra transcatheter pacemaker from the global clinical trial reported a 99.2% implant success rate, low and stable pacing capture thresholds, and a low (4.0%) rate of major complications up to 6 months. OBJECTIVE: The purpose of this report was to describe the prespecified long-term safety objective of Micra at 12 months and electrical performance through 24 months. METHODS: The Micra Transcatheter Pacing Study was a prospective single-arm study designed to assess the safety and efficacy of the Micra VVIR leadless/intracardiac pacemaker...
May 2017: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://www.readbyqxmd.com/read/28111349/long-term-outcomes-in-leadless-micra-transcatheter-pacemakers-with-elevated-thresholds-at-implantation-results-from-the-micra-transcatheter-pacing-system-global-clinical-trial
#7
Jonathan P Piccini, Kurt Stromberg, Kevin P Jackson, Verla Laager, Gabor Z Duray, Mikhael El-Chami, Christopher R Ellis, John Hummel, D Randy Jones, Robert C Kowal, Calambur Narasimhan, Razali Omar, Philippe Ritter, Paul R Roberts, Kyoko Soejima, Shu Zhang, Dwight Reynolds
BACKGROUND: Device repositioning during Micra leadless pacemaker implantation may be required to achieve optimal pacing thresholds. OBJECTIVE: The purpose of this study was to describe the natural history of acute elevated Micra vs traditional transvenous lead thresholds. METHODS: Micra study VVI patients with threshold data (at 0.24 ms) at implant (n = 711) were compared with Capture study patients with de novo transvenous leads at 0.4 ms (n = 538)...
May 2017: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://www.readbyqxmd.com/read/28040461/the-micra-leadless-transcatheter-pacemaker-implantation-and-mid-term-follow-up-results-in-a-single-center
#8
José Luis Martínez-Sande, Javier García-Seara, Moisés Rodríguez-Mañero, Xesús Alberte Fernández-López, Laila González-Melchor, Alfredo Redondo-Diéguez, Rocío González-Ferreiro, José Ramón González-Juanatey
INTRODUCTION AND OBJECTIVES: Currently, studies on the leadless pacemaker (Micra) have mostly been limited to clinical trials with less than 6 months' follow-up and they often fail to reflect real population outcomes. We sought to evaluate electrical parameters at implantation and chronologically during follow-up, as well as the safety of this new technique. METHODS: This prospective, observational study included 30 consecutive patients, all ≥ 65 years, with an indication for single-chamber pacemaker implantation...
December 28, 2016: Revista Española de Cardiología
https://www.readbyqxmd.com/read/27908571/selection-of-the-best-of-2016-on-cardiac-pacing-leadless-pacing
#9
María Luisa Fidalgo Andrés, Lluis Mont Girbau, Diego Lorente Carreño, Marta Pombo Jiménez, Oscar Cano Pérez, Julia Martín Fernández
No abstract text is available yet for this article.
January 2017: Revista Española de Cardiología
https://www.readbyqxmd.com/read/27889044/leadless-pacemakers
#10
REVIEW
Mikhael F El-Chami, Faisal M Merchant, Angel R Leon
Leadless pacing is an emerging technology with the potential to significantly improve outcomes associated with the need for long-term pacing. Specifically, the major advantage of leadless systems is abolishing the need for transvenous leads and subcutaneous pockets, both of which account for most adverse events associated with traditional pacemakers. Two leadless pacemakers are currently available: the Nanostim (leadless cardiac pacemaker [LCP]) device (St. Jude Medical, Sylmar, California) and the Micra Transcatheter pacing system (Medtronic, Minneapolis, Minnesota)...
January 1, 2017: American Journal of Cardiology
https://www.readbyqxmd.com/read/27861115/leadless-cardiac-pacing-what-primary-care-providers-and-non-ep-cardiologists-should-know
#11
REVIEW
Erich L Kiehl, Daniel J Cantillon
Over the last 50 years, the use of transvenous pacemakers has been constrained by long-term complications that affect more than 1 in 10 patients, largely attributable to the endovascular leads and surgical pocket. Leadless cardiac pacing involves a self-contained pacemaker deployed directly into the heart without a lead or incisional access. The procedure has shown promise, eliminating pocket-related complications. Other advantages include postprocedural shoulder mobility and the ability to drive, shower, and bathe...
November 2016: Cleveland Clinic Journal of Medicine
https://www.readbyqxmd.com/read/27855290/transcatheter-leadless-cardiac-pacing-the-new-alternative-solution
#12
Antoine Da Costa, Amandine Axiotis, Cécile Romeyer-Bouchard, Loucif Abdellaoui, Zahi Afif, Jean Baptiste Guichard, Antoine Gerbay, Karl Isaaz
INTRODUCTION: A lack of information about the feasibility and safety of leadless pacemaker (LPMs) exists in a fragile population of patients with limited venous anatomy access or conventional pacemaker (PM) contraindication. Accordingly, the goal of this prospective observational study was to report our experience with this new leadless technology in a subset of patients with contraindication or limited venous access. METHODS AND RESULTS: Between May 2015 and July 2016, 14 patients were consecutively included...
January 15, 2017: International Journal of Cardiology
https://www.readbyqxmd.com/read/27849261/leadless-pacemaker-a-new-concept-in-cardiac-pacing
#13
Nicodemus Lopes, Diogo Cavaco, Pedro Carmo, Maurício Ibrahim Scanavacca, Pedro Adragão
No abstract text is available yet for this article.
October 2016: Arquivos Brasileiros de Cardiologia
https://www.readbyqxmd.com/read/27799257/defibrillators-selecting-the-right-device-for-the-right-patient
#14
Sana M Al-Khatib, Paul Friedman, Kenneth A Ellenbogen
Advances in the field of defibrillation have brought to practice different types of devices that include the transvenous implantable cardioverter-defibrillator (ICD) with or without cardiac resynchronization therapy, the subcutaneous ICD (S-ICD), and the wearable cardioverter-defibrillator. To ensure optimal use of these devices and to achieve best patient outcomes, clinicians need to understand how these devices work, learn the characteristics of patients who qualify them for one type of device versus another, and recognize the remaining gaps in knowledge surrounding these devices...
November 1, 2016: Circulation
https://www.readbyqxmd.com/read/27676167/leadless-cardiac-pacing
#15
Arun Gopi
No abstract text is available yet for this article.
March 2016: Indian Pacing and Electrophysiology Journal
https://www.readbyqxmd.com/read/27660571/pacing-without-wires-leadless-cardiac-pacing
#16
REVIEW
Michael L Bernard
BACKGROUND: Worldwide, more than 700,000 pacemakers are implanted annually with more than 250,000 implanted in the United States. Since the first fully transvenous pacemaker implantations in the early 1960s, great technologic advances have been made in pacing systems. However, the combination of subcutaneous pulse generators and transvenous pacing leads has remained constant for more than 50 years. Leadless pacing systems offer an alternative to traditional pacing systems by eliminating the need for permanent transvenous leads while providing therapy for patients with bradyarrhythmias...
2016: Ochsner Journal
https://www.readbyqxmd.com/read/27600684/how-to-implant-a-leadless-pacemaker-with-a-tine-based-fixation
#17
Mikhael F El-Chami, Paul R Roberts, Alex Kypta, Pamela Omdahl, Matthew D Bonner, Robert C Kowal, Gabor Z Duray
Two major studies have shown that leadless pacemakers are safe and effective for patients requiring right ventricular rate responsive pacing therapy. This positive result recently led to FDA approval of one of the available leadless pacing devices. While this new technology is promising, it requires a different skill set for safe implantation. In this article, we review in detail the different steps required for implantation of tine-based leadless pacemakers while providing tips and tricks to minimize complications...
December 2016: Journal of Cardiovascular Electrophysiology
https://www.readbyqxmd.com/read/27577107/cardiac-resynchronization-therapy-results-challenges-and-perspectives-for-the-future
#18
Marcus Ståhlberg, Frieder Braunschweig, Fredrik Gadler, Lars Mortensen, Lars H Lund, Cecilia Linde
Heart failure (HF) is considered as an epidemic and affects 2% of the population in the Western world. About 15-30% of patients with HF and reduced ejection fraction (HFrEF) also have prolonged QRS duration on the surface ECG, most commonly as a result of left-bundle branch block (LBBB). Increased QRS duration is a marker of a dyssynchronous activation, and subsequent contraction, pattern in the left ventricle (LV). When dyssynchrony is superimposed on the failing heart it further reduced systolic function and ultimately worsens outcome...
October 2016: Scandinavian Cardiovascular Journal: SCJ
https://www.readbyqxmd.com/read/27355553/a-leadless-intracardiac-transcatheter-pacing-system
#19
LETTER
Kim H Chan, Michele McGrady, Ian Wilcox
No abstract text is available yet for this article.
June 30, 2016: New England Journal of Medicine
https://www.readbyqxmd.com/read/27355552/a-leadless-intracardiac-transcatheter-pacing-system
#20
LETTER
Dwight W Reynolds, Philippe Ritter
No abstract text is available yet for this article.
June 30, 2016: New England Journal of Medicine
keyword
keyword
107110
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"